A double blind study of the influence of dipropylacetate on behaviour.
The influence of dipropylacetate (D.P.A.) on behaviour was studied in 20 patients using a double blind cross over trial. 5 patients were rated as improved on D.P.A., 6 on placebo, 3 as deteriorated on D.P.A., 3 on placebo, 12 as unchanged on D.P.A. and 11 on placebo. This study gives us no reason to believe that D.P.A. exerts a psychotropic action within 3 weeks which is better than a placebo effect.
D000293:Adolescent; D000328:Adult; D001519:Behavior / Q000187:drug effects*; D002648:Child; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D004827:Epilepsy / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006801:Humans; D008297:Male; D010919:Placebos; D011619:Psychotropic Drugs; D013997:Time Factors; D014631:Valerates / Q000494:pharmacology*; D014635:Valproic Acid / Q000494:pharmacology* / Q000627:therapeutic use
D010919:Placebos; D011619:Psychotropic Drugs; D014631:Valerates; D014635:Valproic Acid